Acutaas Chemicals Limited (NSE:ACUTAAS)
India · Delayed Price · Currency is INR 3,994.80
+77.90 (1.99%)
Nov 12, 2026, 3:10 PM IST
Acutaas Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 15,925 | 13,394 | 10,069 | 7,175 | 6,167 | 5,201 |
| 15,925 | 13,394 | 10,069 | 7,175 | 6,167 | 5,201 | |
Revenue Growth | 45.18% | 33.02% | 40.34% | 16.33% | 18.57% | 52.71% |
Cost of Revenue | 6,532 | 5,814 | 5,624 | 4,159 | 3,348 | 2,762 |
Gross Profit | 9,393 | 7,580 | 4,445 | 3,016 | 2,819 | 2,439 |
Selling, General & Admin | 1,451 | 1,179 | 839.75 | 633.91 | 492.13 | 417.35 |
Other Operating Expenses | 1,704 | 1,591 | 1,284 | 1,097 | 1,093 | 970.26 |
Operating Expenses | 3,575 | 3,130 | 2,390 | 1,891 | 1,709 | 1,488 |
Operating Income | 5,818 | 4,450 | 2,055 | 1,124 | 1,110 | 950.95 |
Interest Expense | -36.9 | -27.51 | -55.55 | -59.4 | -24.12 | -64.07 |
Interest & Investment Income | 85.45 | 85.45 | 107.96 | 21.32 | 21.79 | 25.82 |
Currency Exchange Gain (Loss) | 324.73 | 324.73 | 61.19 | 41.89 | 21.32 | 1.32 |
Other Non Operating Income (Expenses) | -193.92 | -5.17 | -6.63 | 9.62 | 0.09 | 0.49 |
EBT Excluding Unusual Items | 5,997 | 4,827 | 2,161 | 1,138 | 1,129 | 914.5 |
Gain (Loss) on Sale of Assets | 0.15 | 0.15 | 0.14 | 2.08 | -7.47 | - |
Other Unusual Items | - | - | - | -320.84 | - | - |
Pretax Income | 5,997 | 4,827 | 2,162 | 819.01 | 1,122 | 914.5 |
Income Tax Expense | 1,611 | 1,264 | 557.45 | 331.93 | 288.82 | 195.04 |
Earnings From Continuing Operations | 4,386 | 3,564 | 1,604 | 487.08 | 832.9 | 719.46 |
Minority Interest in Earnings | 5.13 | -1.14 | -17.04 | -59.35 | - | - |
Net Income | 4,392 | 3,563 | 1,587 | 427.73 | 832.9 | 719.46 |
Net Income to Common | 4,392 | 3,563 | 1,587 | 427.73 | 832.9 | 719.46 |
Net Income Growth | 96.08% | 124.46% | 271.06% | -48.65% | 15.77% | 33.24% |
Shares Outstanding (Basic) | 82 | 82 | 80 | 73 | 73 | 68 |
Shares Outstanding (Diluted) | 82 | 82 | 80 | 73 | 73 | 68 |
Shares Change | 0.55% | 2.51% | 9.26% | 0.63% | 6.53% | 8.59% |
EPS (Basic) | 53.65 | 43.51 | 19.81 | 5.83 | 11.43 | 10.52 |
EPS (Diluted) | 53.38 | 43.37 | 19.81 | 5.83 | 11.43 | 10.51 |
EPS Growth | 94.99% | 118.95% | 239.77% | -48.99% | 8.70% | 22.70% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 608.42 | -358.05 | -763 | -1,895 | -128.19 | -456.93 |
Free Cash Flow Per Share | 7.40 | -4.36 | -9.52 | -25.84 | -1.76 | -6.68 |
Dividend Per Share | - | 2.500 | 1.500 | 3.000 | 1.500 | 1.500 |
Dividend Growth | - | 66.67% | -50.00% | 100.00% | 0% | - |
Gross Margin | 58.98% | 56.59% | 44.14% | 42.03% | 45.71% | 46.90% |
Operating Margin | 36.53% | 33.22% | 20.41% | 15.67% | 18.00% | 18.28% |
Profit Margin | 27.58% | 26.60% | 15.76% | 5.96% | 13.51% | 13.83% |
Free Cash Flow Margin | 3.82% | -2.67% | -7.58% | -26.41% | -2.08% | -8.79% |
EBITDA | 6,225 | 4,797 | 2,314 | 1,278 | 1,229 | 1,046 |
EBITDA Margin | 39.09% | 35.82% | 22.98% | 17.81% | 19.93% | 20.11% |
D&A For EBITDA | 407.42 | 347.67 | 259.45 | 153.66 | 119.12 | 95.2 |
EBIT | 5,818 | 4,450 | 2,055 | 1,124 | 1,110 | 950.95 |
EBIT Margin | 36.53% | 33.22% | 20.41% | 15.67% | 18.00% | 18.28% |
Effective Tax Rate | 26.86% | 26.18% | 25.79% | 40.53% | 25.75% | 21.33% |
Revenue as Reported | 16,152 | 13,810 | 10,238 | 7,250 | 6,211 | 5,229 |